Cardiovascular Research Foundation

Since its inception in 1991, CRF has played a major role in realizing dramatic improvements in treating heart disease by establishing the safe use of new technologies, drugs, and therapies in interventional cardiovascular medicine. Guided by visionary physicians who are passionate about advancing the field, CRF's mission is to improve the survival and quality of life for those suffering from heart disease around the world.

Website
http://www.crf.org/

Subscribe to rss feed

Cardiology

Results from the ULTIMATE trial reported

September 24, 2018—The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS ...

Cardiology

Results from the OAC-ALONE trial reported

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable ...

Cardiology

Results from the COAPT trial reported

Data presented today from the randomized COAPT trial, which have the potential to significantly change current clinical practice, found that patients with heart failure and secondary mitral regurgitation (MR) who remained ...

Cardiology

Results from the SOLVE-TAVI trial reported

The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. ...

Cardiology

Results from the DAPT STEMI trial reported

November 1, 2017 - The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ST-elevation myocardial infarction (STEMI) found six months of DAPT was non-inferior to 12 months of ...

page 1 from 8